Apyx Medical (APYX) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$58.4M

Revenue (quarter)

$13.9M

Revenue growth (year over year)

+22.08%

Gross profit (trailing twelve months)

$37.1M

Gross margin

63.50%

Net income (trailing twelve months)

−$8.4M

Net income (quarter)

−$3.1M

Net income growth (year over year)

+17.82%

Net margin

−14.40%

Return on equity

−96.38%

EPS (trailing twelve months)

−$0.20

Book value per share

$0.25

P/E (trailing twelve months)

—

Price to book

9.72

Debt to assets

81.84%

Payout ratio

—

Dividend yield

—

Company profile

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Surgical Aesthetics and Original Equipment Manufacturing (OEM). Its Surgical Aesthetics segment derives the majority of its revenue.

• Is Apyx Medical (APYX) profitable?

  No. Apyx Medical reported a net loss of $8.4M over the trailing twelve months.

• How much revenue does Apyx Medical (APYX) make?

  Apyx Medical generated $58.4M in revenue over the trailing twelve months, up 22.08% year over year.

• How do I buy stock in Apyx Medical (APYX)?

  APYX trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.